AnGes (AMGXF) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 08, 2026)


AMGXF AnGes Inc AMGXF
53 GF Score
Price $0.36
GF Value $0.74
! 5 Warning Signs
View Full Analysis

What is AnGes Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

AnGes's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

AMGXF vs VRTX, REGN, ALNY: Margin of Safety % (DCF Dividends Based) Comparison

For the Biotechnology subindustry, AnGes's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AnGes Margin of Safety % (DCF Dividends Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnGes's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where AnGes's Margin of Safety % (DCF Dividends Based) falls into.


AMGXF
53GF Score
AnGes Inc AMGXF
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AnGes (AMGXF) Overvalued in 2026?

Based on GuruFocus' analysis, AnGes stock appears to be undervalued. The current stock price of $0.36 is trading 51.3% below its estimated GF Value™ of $0.74.

Key valuation signals for AMGXF:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: $0.74 vs. price of $0.36 (51.3% below fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the AMGXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AnGes Business Description

Other Exchanges 4563:JapanAJW:Germany
Address 7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company is involved in research and development and sales of pharmaceuticals such as gene-based drugs (gene therapy products, nucleic acid drugs); contract testing for rare genetic diseases, etc.
53GF Score

Get the complete analysis for AMGXF

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.36
Price
$0.74
GF Value